EXOZYMES (EXOZ) CCO awarded 146,437 options and 62,759 restricted shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
EXOZYMES INC. Chief Commercial Officer Damien Alan Perriman received equity-based compensation on April 1, 2026. He was granted stock options for 146,437 shares of common stock at an exercise price of $9.49 per share and a restricted stock award of 62,759 shares.
The restricted shares vest quarterly at 3,923 shares, with 15,689 shares vesting immediately and a final 3,917-share installment scheduled on April 1, 2029. The options vest monthly at 3,050 shares, with 36,609 shares vesting immediately and a final 3,078-share installment also on April 1, 2029.
After these awards, Perriman directly holds 62,759 common shares from the restricted stock grant and 146,437 stock options, all granted as compensation rather than through open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Perriman Damien Alan
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option for Common Stock | 146,437 | $0.00 | -- |
| Grant/Award | Restricted Stock Grant for Common Stock | 62,759 | $0.00 | -- |
Holdings After Transaction:
Stock Option for Common Stock — 146,437 shares (Direct);
Restricted Stock Grant for Common Stock — 62,759 shares (Direct)
Footnotes (1)
- The shares underlying the grant of the restricted stock vest at a rate of 3,923 shares per quarter, with 15,689 shares vesting immediately. The final vesting installment consists of 3,917 shares on April 1, 2029. The grant and each vesting is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended. The shares underlying the stock option grant vest at a rate of 3,050 shares per month, with 36,609 shares vesting immediately. The final vesting installment consists of 3,078 shares on April 1, 2029. The grant and each exercise of the option is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended.
Key Figures
Stock options granted: 146,437 options
Option exercise price: $9.49 per share
Restricted stock granted: 62,759 shares
+5 more
8 metrics
Stock options granted
146,437 options
Grant to Chief Commercial Officer on April 1, 2026
Option exercise price
$9.49 per share
Exercise price for 146,437 stock options
Restricted stock granted
62,759 shares
Restricted stock award on April 1, 2026
Immediate RSU vesting
15,689 shares
Restricted stock that vested immediately
Quarterly RSU vesting
3,923 shares
Ongoing quarterly vesting rate for restricted stock
Immediate option vesting
36,609 options
Stock options that vested immediately
Monthly option vesting
3,050 options
Ongoing monthly vesting rate for stock options
Final vesting date
April 1, 2029
Final installments for both RSU and option vesting schedules
Key Terms
Restricted Stock Grant, Stock Option for Common Stock, exercise price, vesting, +1 more
5 terms
Restricted Stock Grant financial
"Restricted Stock Grant for Common Stock"
A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.
Stock Option for Common Stock financial
"Stock Option for Common Stock"
exercise price financial
"conversion_or_exercise_price": "9.4900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying the grant of the restricted stock vest at a rate"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Rule 16b-3 regulatory
"The grant and each vesting is pursuant to Rule 16b-3 of Section 16"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
FAQ
What equity awards did EXOZYMES (EXOZ) grant to its Chief Commercial Officer?
EXOZYMES granted Chief Commercial Officer Damien Alan Perriman stock options for 146,437 common shares at a $9.49 exercise price and a restricted stock award of 62,759 common shares. Both awards were issued as compensation, not through open-market transactions, aligning his interests with shareholders.
What are the terms of Damien Perriman’s EXOZ stock options?
Perriman’s EXOZ stock option grant covers 146,437 common shares at a $9.49 exercise price. The options vest at 3,050 shares per month, with 36,609 shares vesting immediately and a final 3,078-share installment scheduled for April 1, 2029, supporting long-term incentive alignment.